@article{oai:niigata-u.repo.nii.ac.jp:00006429,
 author = {Nakamura, Hiroshi and Ito, Seiki and Katagiri, Takashi and Nakagawa, Osamu and Tani, Nagayuki and Shibata, Akira},
 issue = {3},
 journal = {Acta medica et biologica, Acta medica et biologica},
 month = {Sep},
 note = {To study the influence of blood pressure on the anti-proteinuric effect of dipyridamole, 14 diabetic patients with proteinuria were divided into two groups: Group A (n=7) in which the mean blood pressure was always >100 mmHg, and Group B (n=7) in which the mean blood pressure might be > 100 mmHg. During the observation period, protein excretions and serum creatinine (Cr) were examined every six months. In Group A, the urinary protein excretion increased during the control period and decreased during dipyridamole therapy. In Group B, the urinary protein excretion increased both during the control period and dipyridamole therapy. △1/Cr was lowered in Group A, but changed rather dramatically in Group B by dipyridamole therapy. We conclude that the anti-proteinuric effect of dipyridamole was achieved in patients with a mean blood pressure of < 100 mmHg.},
 pages = {153--156},
 title = {Influence of Blood Pressure Level on the Suppression of Proteinuria by Dipyridamole in Diabetic Patients with Nephropathy},
 volume = {44},
 year = {1996}
}